Point State Capital LP Gritstone Bio, Inc. Transaction History
Point State Capital LP
- $4.42 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding GRTS
# of Institutions
12Shares Held
1.2MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY872KShares$26,1590.0% of portfolio
-
Telemetry Investments, L.L.C. New York, NY105KShares$3,1500.57% of portfolio
-
Baader Bank Aktiengesellschaft Unterschleissheim, 2M67.1KShares$2,0140.0% of portfolio
-
Act Capital Management, LLC Wayne, PA47.5KShares$1,4250.17% of portfolio
-
Simplex Trading, LLC44.2KShares$1,3260.0% of portfolio
About Gritstone bio, Inc.
- Ticker GRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,006,896
- Market Cap $2.19M
- Description
- Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...